• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    VITAS® Healthcare, Leading Hospice Provider, Named a 2025 Top Workplace in Healthcare by Top Workplaces USA

    9/25/25 11:48:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email

    MIRAMAR, Fla., Sept. 25, 2025 /PRNewswire/ -- VITAS Healthcare, the nation's leading provider of end-of-life care, has been named a 2025 Top Workplace in Healthcare by Top Workplaces USA, a national program that honors organizations based solely on employee feedback. VITAS is one of only 57 healthcare organizations nationwide with more than 1,000 employees to receive this distinction.

    The award reflects VITAS' ongoing commitment to fostering a purpose-driven culture that supports its employees and enhances the quality of hospice and palliative care delivered to patients and families.

    "This honor belongs to our employees," said Ava Padmore-Lewis, senior vice president and chief human resources officer for VITAS. "Their compassion, dedication and purpose-driven work are what make VITAS a special place for patients, families and each other. I am proud of the culture they have created and the difference they make every day."

    Employee voices were central to the recognition, underscoring the organization's longstanding commitment to its people and mission. VITAS team members were invited to share their experiences in a confidential survey earlier this year. Responses measured key drivers of engaged workplace cultures, including alignment, connection and purpose.

    One anonymous employee stated, "I'm in love with the culture at VITAS. The mentality to help each other makes you feel like you're never alone. To be able to work with leaders who will listen to your concerns and help you work through those concerns is truly one of a kind."

    "I would recommend VITAS as a great place to work," said another undisclosed employee. "The leaders genuinely care for their employees' success and have created a supportive environment. They encourage a culture of kindness, respect and integrity, which our leadership best exemplifies."

    VITAS continues to invest in its workforce through career development programs, employee recognition platforms, and new technologies that enhance collaboration and productivity. In 2023, VITAS received a best-in-class award from the HRO Today Association for excellence in employee experience in healthcare.

    Founded in 1978, VITAS today employs nearly 12,000 professionals across 15 states and the District of Columbia, delivering compassionate hospice and palliative care to 22,000 seriously ill patients each day.

    VITAS is hiring! Join a team where purpose meets compassion. Explore meaningful job opportunities at careers.vitas.com.

    About VITAS® Healthcare

    VITAS Healthcare is the nation's leading provider of end-of-life care. For almost 50 years, VITAS (pronounced VEE-tahs) has delivered compassionate hospice and palliative care to seriously ill patients and their families. Headquartered in Miramar, Florida, the company operates 58 service areas across 15 states (Alabama, California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. 

    VITAS cares for more than 22,000 patients daily, primarily wherever they call home, as well as in its inpatient hospice settings and through partnerships with hospitals, nursing homes and assisted living communities. With a team of nearly 12,000 employees, VITAS was named a 2025 Top Workplace in Healthcare. Visit www.vitas.com.

    Media inquiries contact: [email protected], 877-848-2701 

    Established in 1978, VITAS Healthcare is the nation's leading provider of end-of-life care. For more information, visit VITAS.com. (PRNewsfoto/VITAS Healthcare)

    VITAS Healthcare is among an elite group of organizations named to the 2025 list of Top Workplaces in the Healthcare Industry.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vitas-healthcare-leading-hospice-provider-named-a-2025-top-workplace-in-healthcare-by-top-workplaces-usa-302567348.html

    SOURCE VITAS Healthcare

    Get the next $CHE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    2/27/2026$422.00Outperform → Sector Perform
    RBC Capital Mkts
    1/22/2026$475.00Buy → Hold
    Jefferies
    9/2/2025$550.00Hold → Buy
    Jefferies
    7/25/2025$500.00Hold
    Jefferies
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference

    CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday, March 19, 2026, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITA

    3/12/26 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Reports Fourth-Quarter 2025 Results

    CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results: Revenue was $639.3 million, essentially flat with the fourth quarter of 2024GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0%Adjusted Diluted EPS of $6.42, a decrease of 6.0% VITAS s

    2/25/26 4:15:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents

    CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend

    2/13/26 1:20:02 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chemed downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Chemed from Outperform to Sector Perform and set a new price target of $422.00

    2/27/26 8:26:46 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed downgraded by Jefferies with a new price target

    Jefferies downgraded Chemed from Buy to Hold and set a new price target of $475.00

    1/22/26 8:25:02 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed upgraded by Jefferies with a new price target

    Jefferies upgraded Chemed from Hold to Buy and set a new price target of $550.00

    9/2/25 8:21:04 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Mcnamara Kevin J sold $806,360 worth of Capital Stock (2,000 units at $403.18), decreasing direct ownership by 2% to 93,719 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    3/13/26 12:11:01 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Executive vice president Lee Spencer S exercised 499 units of Capital Stock at a strike of $469.56 and covered exercise/tax liability with 154 units of Capital Stock, increasing direct ownership by 2% to 14,912 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    2/17/26 4:50:05 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Vice president Hutton Thomas C covered exercise/tax liability with 72 units of Capital Stock and exercised 199 units of Capital Stock at a strike of $469.56, increasing direct ownership by 0.39% to 32,481 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    2/17/26 4:36:54 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Walsh George J Iii bought $83,420 worth of Capital Stock (200 units at $417.10), increasing direct ownership by 6% to 3,523 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    8/5/25 3:24:17 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    12/30/24 11:10:35 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    SEC Filings

    View All

    SEC Form 10-K filed by Chemed Corp

    10-K - CHEMED CORP (0000019584) (Filer)

    2/27/26 9:36:24 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CHEMED CORP (0000019584) (Filer)

    2/25/26 4:30:37 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by Chemed Corp

    10-Q - CHEMED CORP (0000019584) (Filer)

    10/31/25 9:02:17 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    View All

    VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer

    MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE:CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare. A Media Snippet accompanying this announcement is available by clicking on this link. Westfall has served as CEO since 2016, leading VITAS through a period of meaningful growth, operational transform

    7/30/25 4:22:59 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

    VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

    3/13/24 9:00:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

    Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

    12/18/23 1:20:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/13/24 5:01:01 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/9/23 11:12:43 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/9/22 3:33:36 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Financials

    Live finance-specific insights

    View All

    Chemed Reports Fourth-Quarter 2025 Results

    CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results: Revenue was $639.3 million, essentially flat with the fourth quarter of 2024GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0%Adjusted Diluted EPS of $6.42, a decrease of 6.0% VITAS s

    2/25/26 4:15:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents

    CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend

    2/13/26 1:20:02 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26

    CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/srzsz65g. Part

    1/2/26 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care